Pioletti and colleagues at EPFL start-up flowbone have developed an injectable hydrogel that targets rapid, localized increase in bone density. The team, in collaboration with Vincent Stadelmann at the Schulthess Klinik, Zurich, have recently reported a novel therapy that combines these hydrogel injections with traditional systemic drugs.

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a study published in Advanced Functional Materials.

A multi-task learning framework, DEMENTIA, has been developed by Prof. Li Hai and his team at the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, to improve the early detection and assessment of Alzheimer’s disease (AD). The research was recently published in the IEEE Journal of Biomedical and Health Informatics.

Some health problems, including chronic pain, inflammation and neurological diseases, can be treated by nerve stimulation, for example, with the help of electrodes that are attached to the ear and activate the vagus nerve. This method is sometimes referred to as an “electric pill.”

A compound with the unpresuming designation of EBC-46 has made a splash in recent years for its cancer-fighting prowess. Now a new study led by Stanford researchers has revealed that EBC-46 also shows immense potential for eradicating human immunodeficiency virus (HIV) infections.